This study demonstrated that fluticasone propionate powder , at the conventional recommended doses of up to 200 microg/day administered by means of Diskus or Diskhaler , was well tolerated and improved lung function in children even as young as 4 and 5 years old regardless of whether they were previously treated with inhaled corticosteroids or cromolyn or beta2-agonists alone .
